Trastuzumab-associated cardiac events in the Persephone trial.

about

Trastuzumab cardiotoxiciy: the age-old balance of risk and benefit.Adjuvant trastuzumab duration trials in HER2 positive breast cancer - what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results.

P2860

Q47169897-EA2910F5-C0BF-47A7-B4D2-569F6FF2A277 Q55181611-D8B05C10-90AD-446F-9BE5-79A7C4816CE6

P2860

Trastuzumab-associated cardiac events in the Persephone trial.

Item

http://www.wikidata.org/entity/Q39163356

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Trastuzumab-associated cardiac events in the Persephone trial.

@en

Trastuzumab-associated cardiac events in the Persephone trial.

@nl

type

Item

label

Trastuzumab-associated cardiac events in the Persephone trial.

@en

Trastuzumab-associated cardiac events in the Persephone trial.

@nl

prefLabel

Trastuzumab-associated cardiac events in the Persephone trial.

@en

Trastuzumab-associated cardiac events in the Persephone trial.

@nl

P1476

Trastuzumab-associated cardiac events in the Persephone trial.

@en

P2093

Adrian Harnett

http://www.w3.org/2001/XMLSchema#string

Anne-Laure Vallier

http://www.w3.org/2001/XMLSchema#string

Chris Plummer

http://www.w3.org/2001/XMLSchema#string

David A Cameron

http://www.w3.org/2001/XMLSchema#string

David Miles

http://www.w3.org/2001/XMLSchema#string

Ioannis Gounaris

http://www.w3.org/2001/XMLSchema#string

Jean Abraham

http://www.w3.org/2001/XMLSchema#string

Karen McAdam

http://www.w3.org/2001/XMLSchema#string

Louise Hiller

http://www.w3.org/2001/XMLSchema#string

Luke Hughes-Davies

http://www.w3.org/2001/XMLSchema#string

P2860

Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Cardiac dysfunction in the trastuzumab clinical trials experience

DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.

Trastuzumab-induced cardiac dysfunction: A 'dual-hit'

Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.

P2888

bjc.2016.357

P304

1462-1470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.357

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27875516

http://www.w3.org/2001/XMLSchema#string

P932

5155357

http://www.w3.org/2001/XMLSchema#string

Trastuzumab-associated cardiac events in the Persephone trial.

about

P2860

P2860

Trastuzumab-associated cardiac events in the Persephone trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932